Market Cap | ₹1,06,634Cr |
ROE | 13.89% |
P/E Ratio(TTM) | 56.33 |
EPS(TTM) | 45.86 |
P/B Ratio | 7.44 |
Dividend Yield | 0.00% |
Industry P/E | 35.31 |
Book Value | 347.23 |
Debt to Equity | 0.59 |
Face Value | 1 |
Parent Organisation | Mankind Pharma |
Managing Director | Mr. Rajeev Juneja |
NSE Symbol | MANKIND |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 37.07 | ||
Cipla | NA (0.00%) | 23.19 | ||
Dr Reddy's Laboratories | NA (0.00%) | 19.11 | ||
Zydus Lifesciences | NA (0.00%) | 22.81 |